FDA Inspection 1066750 — Octapharma Plasma, Inc. Portsmouth

Octapharma Plasma, Inc. Portsmouth — FEI 3007166600

The FDA completed an inspection of Octapharma Plasma, Inc. Portsmouth on Sep 26, 2018 in Portsmouth, VA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 26, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Portsmouth, VA (United States)

Citations

IDCFRDescription
1220321 CFR 606.170(a)Adverse Reaction- Reports of Investigations

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.